Earnings History Data for Catalyst Pharmaceuticals, Inc. (CPRX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2023	AH		CPRX	Catalyst Pharmaceuticals, Inc.	1,480	0.33	0.25	0.20	Catalyst Pharmaceuticals Non-GAAP EPS of $0.53 beats by $0.24, revenue of $99.58M beats by $7.87M [8/9/2023 4:23 PM]	15.00	0.88 (6.24%)	15.03	0.91 (6.44%)	11.09 - 22.11	1,995,014	1,240,000	17,552
Catalyst Pharmaceuticals Non-GAAP EPS of $0.53 beats by $0.24, revenue of $99.58M beats by $7.87M [8/9/2023 4:23 PM]
10-05-2023	AH	4:10 PM ET (May 10)	CPRX	Catalyst Pharmaceuticals, Inc.	1,840	0.26	0.30	0.12	Catalyst Pharmaceuticals beats Q1 top and bottom line estimates; reaffirms FY23 outlook [5/10/2023 4:38 PM]	14.21	-3.30 (-18.85%)	17.64	0.13 (0.74%)	6.15 - 22.11	6,764,799	1,550,000	13,145
Catalyst Pharmaceuticals beats Q1 top and bottom line estimates; reaffirms FY23 outlook [5/10/2023 4:38 PM]
15-03-2023	AH	4:10 PM ET (Mar 15)	CPRX	Catalyst Pharmaceuticals, Inc.	1,600	0.22	0.21	0.09	Catalyst Pharmaceuticals Non-GAAP EPS of $0.31 beats by $0.11, revenue of $60.76M beats by $0.12M [3/15/2023 4:19 PM]	15.77	1.43 (9.94%)	14.60	0.26 (1.81%)	6.15 - 22.11	2,703,979	1,750,000	11,834
Catalyst Pharmaceuticals Non-GAAP EPS of $0.31 beats by $0.11, revenue of $60.76M beats by $0.12M [3/15/2023 4:19 PM]
09-11-2022	AH	4:25 PM ET (Nov 9)	CPRX	Catalyst Pharmaceuticals, Inc.	1,550	0.20	0.19	0.10	Catalyst Pharmaceuticals Non-GAAP EPS of $0.26 beats by $0.07, revenue of $57.24M beats by $3.55M [11/9/2022 4:20 PM]	15.38	0.87 (6.00%)	15.80	1.29 (8.89%)	5.24 - 17.22	2,873,699	1,930,000	18,085
Catalyst Pharmaceuticals Non-GAAP EPS of $0.26 beats by $0.07, revenue of $57.24M beats by $3.55M [11/9/2022 4:20 PM] Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update [Nov-09-22 04:11PM] Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates [Nov-09-22 05:35PM]
09-08-2022	AH	4:10 PM ET (Aug 9)	CPRX	Catalyst Pharmaceuticals, Inc.	981.55	0.20	0.17	0.14	Catalyst Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.11, revenue of $53.11M beats by $4.03M, re-affirms FY22 guidance [8/9/2022 4:31 PM]	13.15	2.55 (24.06%)	11.95	1.35 (12.74%)	4.81 - 13.24	3,696,430	1,770,000	22,103
Catalyst Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.11, revenue of $53.11M beats by $4.03M, re-affirms FY22 guidance [8/9/2022 4:31 PM] Catalyst stock rises 20% as Firdapse revenue grows with Ruzurgi woes settled [8/10/2022 1:12 PM]
10-05-2022	AH	4:20 PM ET (May 10)	CPRX	Catalyst Pharmaceuticals, Inc.	742.07	0.12	0.14	0.09	Catalyst Pharmaceuticals Non-GAAP EPS of $0.18, revenue of $43.09M [5/10/2022 4:15 PM]	6.53	-0.40 (-5.84%)	6.90	-0.03 (-0.43%)	4.43 - 8.64	1,274,770	1,430,000	1,352
Catalyst Pharmaceuticals Non-GAAP EPS of $0.18, revenue of $43.09M [5/10/2022 4:15 PM] Catalyst Pharmaceuticals Q1 earnings rise Y/Y; reaffirms FY22 revenue outlook [5/11/2022 12:49 PM] Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates [May-09-22 05:45PM] Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates [May-10-22 05:25PM] Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update [May-10-22 04:11PM] Catalyst Pharmaceuticals (NASDAQ:CPRX) pulls back 10% this week, but still delivers shareholders solid 27% CAGR over 5 years [May-11-22 06:05AM]
16-03-2022	AH	4:15 PM ET (Mar 16)	CPRX	Catalyst Pharmaceuticals, Inc.	786.79	0.09	0.12	0.11	Catalyst Pharmaceuticals GAAP EPS of $0.09 misses by $0.03, revenue of $38.31M beats by $0.13M [3/16/2022 4:23 PM]	7.35	-0.54 (-6.84%)	7.50	-0.39 (-4.94%)	4.15 - 8.30	1,142,081	1,090,198	23,633
Catalyst Pharmaceuticals GAAP EPS of $0.09 misses by $0.03, revenue of $38.31M beats by $0.13M [3/16/2022 4:23 PM] Catalyst Pharmaceuticals' quarterly net gain narrows though revenue increases [3/16/2022 5:52 PM] Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year? [Mar-16-22 09:40AM] Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-16-22 04:21PM] Catalyst Pharmaceutical (CPRX) Q4 Earnings Lag Estimates [Mar-16-22 05:45PM]
09-11-2021	AH	4:40 PM ET (Nov 9)	CPRX	Catalyst Pharmaceuticals, Inc.	644.80	0.10	0.10	0.11	Catalyst Pharmaceuticals EPS beats by $0.04, beats on revenue [11/9/2021 4:35 PM]	6.46	0.29 (4.70%)	6.27	0.10 (1.62%)	3.22 - 6.66	1,076,859	710,000	4,707
Catalyst Pharmaceuticals EPS beats by $0.04, beats on revenue [11/9/2021 4:35 PM] Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results [Nov-09-21 04:14PM] Catalyst Pharmaceutical (CPRX) Q3 Earnings Meet Estimates [Nov-09-21 06:35PM]
09-08-2021	AH	5:30 PM ET (Aug 9)	CPRX	Catalyst Pharmaceuticals, Inc.	607.78	0.14	0.09	0.09	Catalyst Pharmaceuticals EPS beats by $0.01, beats on revenue [8/9/2021 4:42 PM]	5.93	0.17 (2.86%)	5.92	0.16 (2.78%)	2.88 - 6.22	648,586	700,000	6,158
Catalyst Pharmaceuticals EPS beats by $0.01, beats on revenue [8/9/2021 4:42 PM] Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-09-21 04:39PM] Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates [Aug-09-21 06:55PM]
10-05-2021	AH	5:25 PM ET (May 10)	CPRX	Catalyst Pharmaceuticals, Inc.	484.86	0.09	0.09	0.10	Catalyst Pharmaceuticals EPS misses by $0.02, misses on revenue [5/10/2021 5:34 PM]	4.73	-0.09 (-1.87%)	4.61	-0.21 (-4.36%)	2.88 - 5.19	1,215,296	1,280,000	18,392
Catalyst Pharmaceuticals EPS misses by $0.02, misses on revenue [5/10/2021 5:34 PM] Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update [May-10-21 05:29PM] Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates [May-10-21 07:05PM] Catalyst Pharmaceuticals, Inc. to Host Earnings Call [May-11-21 06:30AM] Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? [May-11-21 03:06AM]
15-03-2021	AH	5:20 PM ET (Mar 15)	CPRX	Catalyst Pharmaceuticals, Inc.	390.75	0.11	0.09	0.07	Catalyst Pharmaceuticals EPS beats by $0.02, beats on revenue [3/15/2021 5:29 PM]	4.13	0.19 (4.82%)	3.95	0.01 (0.25%)	2.56 - 5.19	2,105,359	1,488,808	34,337
Catalyst Pharmaceuticals EPS beats by $0.02, beats on revenue [3/15/2021 5:29 PM] Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update [Mar-15-21 05:26PM] Catalyst Pharmaceutical (CPRX) Beats Q4 Earnings and Revenue Estimates [Mar-15-21 06:45PM] Catalyst Pharmaceuticals, Inc. to Host Earnings Call [Mar-16-21 06:30AM] Catalyst Pharma 4Q Revenue, Earnings Outperform Estimates [Mar-16-21 10:38AM]
09-11-2020	AH	4:15 PM ET (Nov 10)	CPRX	Catalyst Pharmaceuticals, Inc.	344.53	0.11	0.09	0.13	Catalyst Pharmaceuticals EPS beats by $0.31, misses on revenue [11/9/2020 5:24 PM]	3.39	0.08 (2.42%)	3.42	0.11 (3.32%)	2.55 - 5.28	1,733,537	1,358,702	3,939

10-08-2020	AH	4:15 PM ET (Aug 10)	CPRX	Catalyst Pharmaceuticals, Inc.	428.71	0.09	0.08	0.10	Catalyst Pharmaceuticals EPS in-line, beats on revenue [8/10/2020 4:19 PM]	3.46	-0.81 (-18.99%)	3.90	-0.36 (-8.56%)	2.55 - 7.67	5,020,050	2,106,475	246,045